Leoclan Co 7681.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 7681.T. It has been listed since 2 October 2019. In the fiscal year to 30 September 2025, it reported revenue of ¥21.49bn and net income of ¥152.8m. At that date it held total assets of ¥10.91bn and shareholders' equity of ¥5.63bn.

Leoclan Co. Ltd. engages in the wholesale and repair of medical equipment and devices. The company is headquartered in Settsu-Shi, Osaka-Fu. The company went IPO on 2019-10-02. The firm operates in three business segments. The Medical Total Solution segment is engaged in the contract sale of medical equipment and medical information system products based on consulting for medical institutions, prevention and examination facilities, nursing care and welfare facilities, as well as the related maintenance services business, the building interior work and medical equipment construction business. The Remote Image Diagnosis Service segment is engaged in the provision of remote diagnosis services through image data taken by magnetic resonance imaging (MRI) and computed tomography (CT) for medical institutions without a radiation diagnosis specialist. The Provide Lunch segment is engaged in the provision of ordinary and recuperation meal services for nursing and welfare facilities.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Shogo SugitaChairman of the Board, Representative Director, since 2001
• Mr. Koji TakeuchiPresident, Representative Director, since 2001
• Mr. Terumi TsutsuiChief Director of Administration, Director, since 2002
• Mr. Takashi HirokawaDirector, since 2002
• Mr. Shiro OgasawaraIndependent Director
• Mr. Kenji OzakiIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.